Syndromic diaphragmatic or thoracic malformation

Syndromic diaphragmatic or thoracic malformation is a broad grouping category used by Orphanet (ORPHA:180779) to classify rare genetic conditions in which diaphragmatic defects (such as congenital diaphragmatic hernia) or thoracic cage malformations occur as part of a recognized syndrome — meaning they appear alongside other congenital anomalies rather than in isolation. The diaphragm and thoracic structures are the primary systems affected, but because these are syndromic forms, additional organ systems are frequently involved, including the cardiovascular, skeletal, neurological, and genitourinary systems, depending on the specific underlying syndrome. Conditions grouped under this category include, among others, Fryns syndrome, Donnai-Barrow syndrome, Matthew-Wood syndrome, and various chromosomal anomalies that feature diaphragmatic hernia or thoracic wall defects as a core component. Key clinical features typically include respiratory distress at birth due to diaphragmatic hernia or thoracic deformity, pulmonary hypoplasia, and a variable constellation of additional malformations such as cardiac defects, limb anomalies, craniofacial dysmorphism, and intellectual disability. Because this is a classification grouping rather than a single disease entity, the inheritance pattern, age of onset, and prognosis vary widely depending on the specific syndrome diagnosed. Management generally requires multidisciplinary care, often including neonatal surgical repair of diaphragmatic hernias, respiratory support, cardiac evaluation, and long-term developmental follow-up. Genetic counseling is essential for affected families, and molecular genetic testing can help identify the specific underlying condition to guide prognosis and recurrence risk assessment.

Common questions about Syndromic diaphragmatic or thoracic malformation